Drug intelligence / Profile preview

Lipotriad Visionary

Development stage
Unknown
Lead developer
Lipotriad Vitamins
Modality
Small Molecules
Administration
Oral
01

Overview

Lipotriad Visionary is a multi-ingredient dietary supplement formulated to support eye and macular health, specifically targeting adults over the age of 50. Developed and marketed by Lipotriad LLC, the product is based on the AREDS2 (Age-Related Eye Disease Study 2) formula but utilizes a low-zinc concentration (17mg) and is entirely free of beta-carotene, making it a safer option for smokers. The supplement contains six key ingredients: lutein (10mg), zeaxanthin (2.5mg), vitamin C, vitamin E, zinc, and copper, supplemented with 250mg of fish oil. It is administered as a once-daily, dye-free softgel. While marketed for the support of macular health and the prevention of disease progression, it is classified as a nutritional supplement rather than an FDA-approved pharmaceutical drug, and the manufacturer received an FDA warning in 2021 regarding unapproved drug claims.

Brand names
Lipotriad Visionary
02

Targets

Misfolded SOD1

Beyond the preview

Go deeper on Lipotriad Visionary.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipotriad Visionary.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call